VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ADGM
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ADGMAdagio Medical Holdings, Inc.
$0.65$10M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksADGMQuarterly Financials

Adagio Medical Holdings, Inc. (ADGM) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Adagio Medical Holdings, Inc. (ADGM) quarterly income statement — complete revenue, gross profit & net income history

ADGM Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22
Sales/Revenue00000-143K185K254K26K78K41K121K60K0
Revenue Growth %-100%-100%-100%-100%-283.33%351.22%109.92%-56.67%-----
Cost of Goods Sold058K31K342K253K299K571K682K542K334K253K401K318K291K
COGS % of Revenue------209.09%308.65%268.5%2084.62%428.21%617.07%331.4%530%-
Gross Profit0-58K-31K-342K-253K-442K-386K-428K-516K-256K-212K-280K-258K-291K
Gross Margin %-----309.09%-208.65%-168.5%-1984.62%-328.21%-517.07%-231.41%-430%-
Gross Profit Growth %100%86.88%91.97%20.09%50.97%-72.66%-82.08%-52.86%-100%12.03%----
Operating Expenses5.2M3.91M5.69M4.38M7.14M50.37M10.24M6.23M8.3M5.08M8.87M6.59M6.4M5.92M
OpEx % of Revenue------35222.56%5537.84%2453.15%31919.23%6508.97%21631.71%5449.59%10660%-
Selling, General & Admin2.46M1.68M2.92M002.79M7.78M04.83M3.3M4.45M01.6M1.46M
SG&A % of Revenue------1952.96%4203.78%-18576.92%4234.62%10856.1%-2663.33%-
Research & Development2.74M2.23M2.77M1.97M3.66M3.42M2.47M2.87M3.47M1.77M4.42M4.41M4.8M4.45M
R&D % of Revenue------2389.51%1334.05%1127.95%13342.31%2274.36%10775.61%3643.8%7996.67%-
Other Operating Expenses0001000K1000K1000K01000K0001000K00
Operating Income-5.2M-3.97M-5.72M-4.72M-7.4M-50.78M-10.63M-6.66M-8.81M-5.33M-9.08M-6.87M-6.65M-6.21M
Operating Margin %-----35513.47%-5746.49%-2621.65%-33903.85%-6837.18%-22148.78%-5680.99%-11090%-
Operating Income Growth %29.7%92.19%46.19%29.16%16.09%-852.26%-17.07%3.13%-32.48%14.09%----
EBITDA-4.99M-3.73M-5.53M-4.45M-7.13M-50.36M-10.38M-6.4M-8.48M-5.2M-8.98M-6.73M-6.53M-6.07M
EBITDA Margin %-----35216.96%-5608.11%-2520.47%-32634.62%-6666.67%-21904.88%-5565.29%-10883.33%-
EBITDA Growth %29.97%92.59%46.7%30.55%16.02%-868.47%-15.52%4.93%-29.94%14.38%----
D&A (Non-Cash Add-back)210K237K191K271K271K424K256K257K330K133K100K140K124K135K
EBIT-6.22M-2.53M-9.37M-4.72M-7.4M-56.7M-3.89M-6.66M-7.26M-8.56M-10.28M-6.87M-9.04M-5.89M
Net Interest Income-671K-643K-670K-618K-498K753K-573K0-753K-576K-483K460.36K-232K-133K
Interest Income107K132K79K102K164K753K166K01K1K0460.36K1K4K
Interest Expense778K775K749K720K662K0739K0754K577K485K0233K137K
Other Income/Expense-1.79M662K-4.4M770K-316K2.54M6M925K797K-3.81M-1.68M-1.67M-2.62M176K
Pretax Income-7M-3.31M-10.12M-3.95M-7.71M-48.24M-4.63M-5.73M-8.02M-9.14M-10.76M-8.55M-9.28M-6.03M
Pretax Margin %-----33737.52%-2502.16%-2257.48%-30838.46%-11720.51%-26246.34%-7064.46%-15460%-
Income Tax000009.12M00000000
Effective Tax Rate %0%0%0%0%0%-18.91%0%0%0%0%0%0%0%0%
Net Income-7M-3.31M-10.12M-3.95M-7.71M-52.8M-4.63M-5.73M-8.02M-9.14M-10.76M-8.55M-9.28M-6.03M
Net Margin %-----36925.43%-2502.16%-2257.48%-30838.46%-11720.51%-26246.34%-7064.46%-15460%-
Net Income Growth %9.31%93.74%-118.58%31.16%3.8%-477.59%56.98%32.92%13.56%-51.56%----
Net Income (Continuing)-7M-3.31M-10.12M-3.95M-7.71M-57.37M-4.63M-5.73M-8.02M-9.14M-10.76M-8.55M-9.28M-6.03M
Discontinued Operations00000000000000
Minority Interest00000000000000
EPS (Diluted)-0.31-0.16-0.66-0.35-0.50-3.55-0.32-0.09-0.03-0.28-0.800.050.01-0.31
EPS Growth %38%95.49%-106.25%-275.54%-1482.28%-1167.86%60%-286.4%-398.11%9.68%----
EPS (Basic)-0.31-0.16-0.66-0.26-0.50-3.55-0.32-0.09-0.03-0.28-0.800.050.01-0.31
Diluted Shares Outstanding22.21M20.14M15.38M15.38M15.38M14.87M14.54M7.66M7.78M7.93M13.39M7.43M15.06M19.19M
Basic Shares Outstanding22.21M20.14M15.38M15.38M15.38M14.87M14.54M7.66M7.78M7.93M13.39M7.43M15.06M19.19M
Dividend Payout Ratio--------------